HER-Vaxx(HER-2)
Official Title: A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
Actual Study Start Date :August 30, 2017
Estimated Primary Completion Date :January 2022
Estimated Study Completion Date :February 2022
https://clinicaltrials.gov/ct2/show/study/NCT02795988?term=imugene&draw=2
Don't know if this has been posted already. Hopefully good results from phase 2 trials sometime this week or before the end of the month.
HER-Vaxx(HER-2)Official Title: A Phase 1b/2 Open-Label Study...
-
- There are more pages in this discussion • 21,584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.003(5.26%) |
Mkt cap ! $395.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.7¢ | 5.4¢ | $1.444M | 26.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 3824179 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 172983 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |